Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleBrief Communication

Principal-Component Analysis–Based Measures of PET Data Closely Reflect Neuropathologic Staging Schemes

Ganna Blazhenets, Lars Frings, Arnd Sörensen and Philipp T. Meyer; for the Alzheimer’s Disease Neuroimaging Initiative
Journal of Nuclear Medicine June 2021, 62 (6) 855-860; DOI: https://doi.org/10.2967/jnumed.120.252783
Ganna Blazhenets
Department of Nuclear Medicine, University of Freiburg Medical Center, Freiburg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lars Frings
Department of Nuclear Medicine, University of Freiburg Medical Center, Freiburg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Arnd Sörensen
Department of Nuclear Medicine, University of Freiburg Medical Center, Freiburg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Philipp T. Meyer
Department of Nuclear Medicine, University of Freiburg Medical Center, Freiburg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 62 no. 6 855-860
DOI 
https://doi.org/10.2967/jnumed.120.252783
PubMed 
33097630

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Received for publication June 30, 2020
  • Accepted for publication September 18, 2020
  • Published online June 1, 2021.

Article Versions

  • previous version (October 23, 2020 - 13:48).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2021 by the Society of Nuclear Medicine and Molecular Imaging.

Author Information

  1. Ganna Blazhenets,
  2. Lars Frings,
  3. Arnd Sörensen and
  4. Philipp T. Meyer for the Alzheimer’s Disease Neuroimaging Initiative
  1. Department of Nuclear Medicine, University of Freiburg Medical Center, Freiburg, Germany
  1. For correspondence or reprints contact: Ganna Blazhenets, Hugstetter Strasse 55, 79106, Freiburg, Germany. E-mail: ganna.blazhenets{at}uniklinik-freiburg.de
View Full Text

Statistics from Altmetric.com

Cited By...

  • 5 Citations
  • 6 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Functional brain networks in the evaluation of patients with neurodegenerative disorders
    Matej Perovnik, Tomaž Rus, Katharina A. Schindlbeck, David Eidelberg
    Nature Reviews Neurology 2023 19 2
  • Alzheimer's disease: Potential pathogenesis and imaging findings
    Yan Zhang, Chenpeng Zhang, Jianjun Liu, Hongda Shao
    VIEW 2023 4 5
  • Differential Effects of Tau Stage, Lewy Body Pathology, and Substantia Nigra Degeneration on18F-FDG PET Patterns in Clinical Alzheimer Disease
    Jesús Silva-Rodríguez, Miguel A. Labrador-Espinosa, Alexis Moscoso, Michael Schöll, Pablo Mir, Michel J. Grothe
    Journal of Nuclear Medicine 2023 64 2
  • Principal component analysis of synaptic density measured with [11C]UCB-J PET in early Alzheimer’s disease
    Ryan S. O'Dell, Albert Higgins-Chen, Dhruva Gupta, Ming-Kai Chen, Mika Naganawa, Takuya Toyonaga, Yihuan Lu, Gessica Ni, Anna Chupak, Wenzhen Zhao, Elaheh Salardini, Nabeel B. Nabulsi, Yiyun Huang, Amy F.T. Arnsten, Richard E. Carson, Christopher H. van Dyck, Adam P. Mecca
    NeuroImage: Clinical 2023 39
  • An artificial intelligence-derived metabolic network predicts psychosis in Alzheimer’s disease
    Nha Nguyen, Jesus J Gomar, Jack N Truong, Janos Barbero, Patrick P Do, Andrea Rommal, Alice Oh, David Eidelberg, Jeremy Koppel, An Vo
    Brain Communications 2025 7 3
  • Neuroimaging in Parkinson�s Disease and Related Disorders
    Heather Wilson, Marios Politis
    2023

Article usage

Article usage: October 2020 to May 2025

AbstractFullPdf
Oct 2020324028
Nov 2020214010
Dec 2020124015
Jan 202113709
Feb 202111503
Mar 202111605
Apr 202115306
May 202188015
Jun 20216024255
Jul 20212541214
Aug 20211151018
Sep 20219459
Oct 202197333
Nov 202168526
Dec 2021273218
Jan 202223105
Feb 2022222412
Mar 2022202219
Apr 2022272222
May 2022231824
Jun 2022111618
Jul 2022102514
Aug 2022192322
Sep 202271419
Oct 2022171419
Nov 2022131610
Dec 2022101715
Jan 202352415
Feb 202361711
Mar 2023112517
Apr 202351818
May 202311812
Jun 20231139
Jul 202331013
Aug 2023101113
Sep 202331511
Oct 202371311
Nov 2023697
Dec 20235208
Jan 20245179
Feb 20245810
Mar 202432437
Apr 202425030
May 202445411
Jun 2024114315
Jul 2024128618
Aug 2024109413
Sep 202453012
Oct 2024121519
Nov 202452527
Dec 202472510
Jan 202571916
Feb 2025185121
Mar 202552830
Apr 202563236
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 62 (6)
Journal of Nuclear Medicine
Vol. 62, Issue 6
June 1, 2021
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Principal-Component Analysis–Based Measures of PET Data Closely Reflect Neuropathologic Staging Schemes
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Principal-Component Analysis–Based Measures of PET Data Closely Reflect Neuropathologic Staging Schemes
Ganna Blazhenets, Lars Frings, Arnd Sörensen, Philipp T. Meyer
Journal of Nuclear Medicine Jun 2021, 62 (6) 855-860; DOI: 10.2967/jnumed.120.252783

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Principal-Component Analysis–Based Measures of PET Data Closely Reflect Neuropathologic Staging Schemes
Ganna Blazhenets, Lars Frings, Arnd Sörensen, Philipp T. Meyer
Journal of Nuclear Medicine Jun 2021, 62 (6) 855-860; DOI: 10.2967/jnumed.120.252783
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE
    • ACKNOWLEDGMENTS
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • Differential Effects of Tau Stage, Lewy Body Pathology, and Substantia Nigra Degeneration on 18F-FDG PET Patterns in Clinical Alzheimer Disease
  • Google Scholar

More in this TOC Section

  • Bioanalytic Hybrid System Merging 3-Dimensional Cell Culture and Chromatographic Precision for Unprecedented Preclinical Insights in Molecular Imaging
  • Radiances of Cerenkov-Emitting Radionuclides on the In Vivo Imaging System
  • Measuring Total Metabolic Tumor Volume from 18F-FDG PET: A Reality Check
Show more BRIEF COMMUNICATION

Similar Articles

Keywords

  • 18F-FDG PET
  • amyloid PET
  • Braak tangle stage
  • Thal phase
  • conversion pattern
SNMMI

© 2025 SNMMI

Powered by HighWire